ASCO GI eBook
All our ASCO GI 2023 features in one convenient place! ASCO GI Cancer 2023.indd
Read More
eBook (Meeting Coverage)
ASH Lymphoma eBook
Focus on ASH Lymphoma 2023v2.indd
Read More
ASH 2022: Leukemia eBook
Focus on ASH Leukemia 2023.indd
Read More
AHA 2022 eBook
A curated ebook of recent studies, findings, and thought leader perspectives from AHA 2022.
Read More
ASN 2022 eBook
Focus on ASN Chronic Gout 2022.indd
Read More
ECTRIMS NMOSD eBook
ECTRIMS NMOSD 2022a.indd
Read More
ECTRIMS MS eBook
ECTRIMS MS 2022
Read More
SOHO 2022 eBook
SOHO 2022 Conference Report.indd
Read More
ASCO A Focus On Leukemia eBook
ASCO Leukemia 2022.indd
Read More
ASCO: A Focus on Lung Cancer
ASCO Lung Cancer Annual 2022.indd
Read More
ACTRIMS eBook
Focus on MS MAY 2022v2.indd
Read More
ASH 2021: A Focus on Leukemia & Lymphoma
Focus on Lymphoma Leukemia
Read MorePatients With Non-Hodgkin’s Lymphoma Subtypes Incur High Hospital Costs
According to published data, patients with mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL) experience frequent relapses over the course of...
Read MoreVenetoclax/Idelalisib Regimens Better Option After First-Line Ibrutinib for CLL/SLL
The establishment of ibrutinib as a preferred first-line treatment option makes it important to understand the treatment sequence following first-line ibrutinib and the patient characteristics of those treated with a second-line...
Read MoreDelayed Start of Therapy Feasible in Some Patients With MCL
Currently, the effect of the diagnosis-to-treatment interval (DTI) on survival in patients with mantle cell lymphoma (MCL) has not been extensively examined. Researchers aimed to determine the feasibility of active surveillance...
Read MoreAddition of Ibrutinib to Chemoimmunotherapy in CLL
The combination of fludarabine, cyclophosphamide, and rituximab (FCR) is the only regimen other than allotransplantation shown in studies to result in a significant chance of functional cure in very long-term follow-up for...
Read More
ASN 2021: A Focus on Chronic Gout eBook
Focus on ASN Chronic Gout.indd
Read More
Highlights from ASCO 2021: Leukemia – eBook
ASCO Leukemia Annual Meetingv3 Featuring… ELEVATE-RR: Acalabrutinib demonstrates similar...
Read More